Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1983 Apr;50:91–99. doi: 10.1289/ehp.835091

Modification of the carcinogenic process in colorectal cancer by endogenous and exogenous factors: effect of colestipol hydrochloride on tumors induced by dimethylhydrazine.

J P Daugherty
PMCID: PMC1569246  PMID: 6873034

Abstract

The effect of the bile acid sequestrant, colestipol hydrochloride, on the incidence of dimethylhydrazine-induced tumors of the large intestine was determined in male Swiss mice. The subcutaneous administration of dimethylhydrazine (15 mg/kg) produced tumors in approximately 89% of the animals with an average of 1.70 tumors per tumor-bearing animal. When carcinogen-treated animals received dietary colestipol (0.52%, w/w) from 4 weeks prior to the first injection of dimethylhydrazine until the time of death, there was an increase in the number of tumors per tumor-bearing animal to 2.23. In an attempt to understand the nature of this enhancement, animals were administered dietary colestipol at different times in relation to the administration of the carcinogen. The number of tumors per tumor-bearing animal for the different protocols was: post-initiation colestipol exposure, 1.70; colestipol exposure concomitant with dimethylhydrazine, 1.41; pre-initiation colestipol exposure, 2.23. Thus, colestipol appeared to function both as an anticarcinogen and as a promoter (pre-initiation). Since colestipol has the capacity to bind a number of chemical agents, the different biological effects probably reflect the multifactorial nature of colorectal cancer with the end result dependent on the balance between opposing factors. The selective administration of colestipol in relation to carcinogen administration may prove useful in elucidating the various factors involved in the etiology of this disease.

Full text

PDF
91

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asano T., Pollard M., Madsen D. C. Effects of cholestyramine on 1,2-dimethylhydrazine-induced enteric carcinoma in germfree rats. Proc Soc Exp Biol Med. 1975 Dec;150(3):780–785. doi: 10.3181/00379727-150-39124. [DOI] [PubMed] [Google Scholar]
  2. Barbolt T. A., Abraham R. The effect of bran on dimethylhydrazine-induced colon carcinogenesis in the rat. Proc Soc Exp Biol Med. 1978 Apr;157(4):656–659. doi: 10.3181/00379727-157-40115. [DOI] [PubMed] [Google Scholar]
  3. Bennett A., Del Tacca M. Proceedings: Prostaglandins in human colonic carcinoma. Gut. 1975 May;16(5):409–409. [PubMed] [Google Scholar]
  4. Bennett A., Tacca M. D., Stamford I. F., Zebro T. Prostaglandins from tumours of human large bowel. Br J Cancer. 1977 Jun;35(6):881–884. doi: 10.1038/bjc.1977.132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Broitman S. A. Cholesterol excretion and colon cancer. Cancer Res. 1981 Sep;41(9 Pt 2):3738–3740. [PubMed] [Google Scholar]
  6. Celik C., Mittelman A., Paolini N. S., Jr, Lewis D., Evans J. T. Effects of 1,2-symmetrical dimethylhydrazine on jejunocolic transposition in Sprague-Dawley rats. Cancer Res. 1981 Jul;41(7):2908–2911. [PubMed] [Google Scholar]
  7. Chomchai C., Bhadrachari N., Nigro N. D. The effect of bile on the induction of experimental intestinal tumors in rats. Dis Colon Rectum. 1974 May-Jun;17(3):310–312. doi: 10.1007/BF02586971. [DOI] [PubMed] [Google Scholar]
  8. Clapp N. K., Bowles N. D., Satterfield L. C., Klima W. C. Selective protective effect of butylated hydroxytoluene against 1,2-dimethylhydrazine carcinogenesis in BALB/c mice. J Natl Cancer Inst. 1979 Oct;63(4):1081–1087. [PubMed] [Google Scholar]
  9. Cook M. G., McNamara P. Effect of dietary vitamin E on dimethylhydrazine-induced colonic tumors in mice. Cancer Res. 1980 Apr;40(4):1329–1331. [PubMed] [Google Scholar]
  10. Correa P. Epidemiological correlations between diet and cancer frequency. Cancer Res. 1981 Sep;41(9 Pt 2):3685–3690. [PubMed] [Google Scholar]
  11. Cruse J. P., Lewin M. R., Clark C. G. Colon cancer, bile-salt binding, and aluminium hydroxide. Lancet. 1978 Jun 10;1(8076):1261–1261. doi: 10.1016/s0140-6736(78)92496-0. [DOI] [PubMed] [Google Scholar]
  12. Cruse J. P., Lewin M. R., Clark C. G. Failure of bran to protect against experimental colon cancer in rats. Lancet. 1978 Dec 16;2(8103):1278–1280. doi: 10.1016/s0140-6736(78)92041-x. [DOI] [PubMed] [Google Scholar]
  13. Cruse P., Lewin M. R., Clark C. G. Aluminium hydroxide and colon cancer. Lancet. 1980 Nov 8;2(8202):1030–1030. doi: 10.1016/s0140-6736(80)92186-8. [DOI] [PubMed] [Google Scholar]
  14. Cummings K. B., Robertson R. P. Prostaglandin: increased production by renal cell carcinoma. J Urol. 1977 Nov;118(5):720–723. doi: 10.1016/s0022-5347(17)58172-0. [DOI] [PubMed] [Google Scholar]
  15. Curtiss L. K., Edgington T. S. Regulatory serum lipoproteins: regulation of lymphocyte stimulation by a species of low density lipoprotein. J Immunol. 1976 May;116(5):1452–1458. [PubMed] [Google Scholar]
  16. Deschner E. E. Experimentally induced cancer of the colon. Cancer. 1974 Sep;34(3):suppl–suppl:828. doi: 10.1002/1097-0142(197409)34:3+<824::aid-cncr2820340707>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  17. Drasar B. S., Irving D. Environmental factors and cancer of the colon and breast. Br J Cancer. 1973 Feb;27(2):167–172. doi: 10.1038/bjc.1973.20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Druckrey H., Preussmann R., Matzkies F., Ivankovic S. Selektive Erzeugung von Darmkrebs bei Ratten durch 1,2-Dimethyl-hydrazin. Naturwissenschaften. 1967 Jun;54(11):285–286. doi: 10.1007/BF00620890. [DOI] [PubMed] [Google Scholar]
  19. Eastwood M. A., Fisher N., Greenwood C. T., Hutchinson J. B. Perspectives on the bran hypothesis. Lancet. 1974 May 25;1(7865):1029–1033. doi: 10.1016/s0140-6736(74)90429-2. [DOI] [PubMed] [Google Scholar]
  20. Grundy S. M., Mok H. Y. Colestipol, clofibrate, and phytosterols in combined therapy of hyperlipidemia. J Lab Clin Med. 1977 Feb;89(2):354–366. [PubMed] [Google Scholar]
  21. Heel R. C., Brogden R. N., Pakes G. E., Speight T. M., Avery G. S. Colestipol: a review of its pharmacological properties and therapeutic efficacy in patients with hypercholesterolaemia. Drugs. 1980 Mar;19(3):161–180. doi: 10.2165/00003495-198019030-00001. [DOI] [PubMed] [Google Scholar]
  22. Hill M. J. Colon cancer: a disease of fibre depletion or of dietary excess? Digestion. 1974;11(3-4):289–306. doi: 10.1159/000197593. [DOI] [PubMed] [Google Scholar]
  23. Ho Y. K., Faust J. R., Bilheimer D. W., Brown M. S., Goldstein J. L. Regulation of cholesterol synthesis by low density lipoprotein in isolated human lymphocytes. Comparison of cells from normal subjects and patients with homozygous familial hypercholesterolemia and abetalipoproteinemia. J Exp Med. 1977 Jun 1;145(6):1531–1549. doi: 10.1084/jem.145.6.1531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Jaffe B. M. Prostaglandins and cancer: an update. Prostaglandins. 1974 Jun 25;6(6):453–461. doi: 10.1016/s0090-6980(74)80055-9. [DOI] [PubMed] [Google Scholar]
  25. Ko H., Royer M. E. In vitro binding of drugs to colestipol hydrochloride. J Pharm Sci. 1974 Dec;63(12):1914–1920. doi: 10.1002/jps.2600631218. [DOI] [PubMed] [Google Scholar]
  26. Kritchevsky D., Story J. A. Binding of bile salts in vitro by nonnutritive fiber. J Nutr. 1974 Apr;104(4):458–462. doi: 10.1093/jn/104.4.458. [DOI] [PubMed] [Google Scholar]
  27. Kritchevsky D., Story J. A. Letter: In vitro binding of bile acids and bile salts. Am J Clin Nutr. 1975 Apr;28(4):305–306. doi: 10.1093/ajcn/28.4.305. [DOI] [PubMed] [Google Scholar]
  28. Kulkarni M. S., Heidepriem P. M., Yielding K. L. Production by lithocholic acid of DNA strand breaks in L1210 cells. Cancer Res. 1980 Aug;40(8 Pt 1):2666–2669. [PubMed] [Google Scholar]
  29. Larsen R. M., Ainsworth E. J. A staining technique for spleen nofules. A comparison od Do's. Radiat Res. 1969 Nov;40(2):379–384. [PubMed] [Google Scholar]
  30. Leonard J. P., Desager J. P., Beckers C., Harvengt C. In vitro binding of various biological substances by two hypocholesterolaemic resins. Cholestyramine and colestipol. Arzneimittelforschung. 1979;29(7):979–981. [PubMed] [Google Scholar]
  31. Levine L., Hinkle P. M., Voelkel E. F., Tashjian A. H., Jr Prostaglandin production by mouse fibrosarcoma cells in culture: inhibition by indomethacin and aspirin. Biochem Biophys Res Commun. 1972 May 26;47(4):888–896. doi: 10.1016/0006-291x(72)90576-1. [DOI] [PubMed] [Google Scholar]
  32. Lynch N. R., Salomon J. C. Tumor growth inhibition and potentiation of immunotherapy by indomethacin in mice. J Natl Cancer Inst. 1979 Jan;62(1):117–121. [PubMed] [Google Scholar]
  33. MacGregor G. A. Clofibrate and malignancy. Lancet. 1979 Feb 24;1(8113):445–445. doi: 10.1016/s0140-6736(79)90925-5. [DOI] [PubMed] [Google Scholar]
  34. Miller N. E., Clifton-Bligh P., Nestel P. J., Whyte H. M. Controlled clinical trial of a new bile acid-sequestering resin, colestipol, in the treatment of hypercholesterolaemia. Med J Aust. 1973 Jun 23;1(25):1223–1227. [PubMed] [Google Scholar]
  35. Morse J. H., Witte L. D., Goodman D. S. Inhibition of lymphocyte proliferation stimulated by lectins and allogeneic cells by normal plasma lipoproteins. J Exp Med. 1977 Dec 1;146(6):1791–1803. doi: 10.1084/jem.146.6.1791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Mueller C. E., Thornbury J. R. Adenocarcinoma of the colon complicating ureterosigmoidostomy: a case report and review of the literature. J Urol. 1973 Feb;109(2):225–227. doi: 10.1016/s0022-5347(17)60392-6. [DOI] [PubMed] [Google Scholar]
  37. Narisawa T., Magadia N. E., Weisburger J. H., Wynder E. L. Promoting effect of bile acids on colon carcinogenesis after intrarectal instillation of N-methyl-N'-nitro-N-nitrosoguanidine in rats. J Natl Cancer Inst. 1974 Oct;53(4):1093–1097. doi: 10.1093/jnci/53.4.1093. [DOI] [PubMed] [Google Scholar]
  38. Nigro N. D., Bhadrachari N., Chomchai C. A rat model for studying colonic cancer: effect of cholestyramine on induced tumors. Dis Colon Rectum. 1973 Nov-Dec;16(6):438–443. doi: 10.1007/BF02588866. [DOI] [PubMed] [Google Scholar]
  39. Nigro N. D., Campbell R. L., Gantt J. S., Lin Y. N., Singh D. V. A comparison of the effects of the hypocholesteremic agents, cholestyramine and candicidin, on the induction of intestinal tumors in rats by azoxymethane. Cancer Res. 1977 Sep;37(9):3198–3203. [PubMed] [Google Scholar]
  40. Peraino C., Fry R. J., Staffeldt E., Christopher J. P. Enhancing effects of phenobarbitone and butylated hydroxytoluene on 2-acetylaminofluorene-induced hepatic tumorigenesis in the rat. Food Cosmet Toxicol. 1977 Apr;15(2):93–96. doi: 10.1016/s0015-6264(77)80311-8. [DOI] [PubMed] [Google Scholar]
  41. Pollard M., Luckert P. H. Indomethacin treatment of rats with dimethylhydrazine-induced intestinal tumors. Cancer Treat Rep. 1980;64(12):1323–1327. [PubMed] [Google Scholar]
  42. Pozharisski K. M. The significance of nonspecific injury for colon carcinogenesis in rats. Cancer Res. 1975 Dec;35(12):3824–3830. [PubMed] [Google Scholar]
  43. Reddy B. S., Narasawa T., Weisburger J. H., Wynder E. L. Promoting effect of sodium deoxycholate on colon adenocarcinomas in germfree rats. J Natl Cancer Inst. 1976 Feb;56(2):441–442. doi: 10.1093/jnci/56.2.441. [DOI] [PubMed] [Google Scholar]
  44. Reddy B. S., Watanabe K. Effect of cholesterol metabolites and promoting effect of lithocholic acid in colon carcinogenesis in germ-free and conventional F344 rats. Cancer Res. 1979 May;39(5):1521–1524. [PubMed] [Google Scholar]
  45. Reddy B. S., Watanabe K., Weisburger J. H., Wynder E. L. Promoting effect of bile acids in colon carcinogenesis in germ-free and conventional F344 rats. Cancer Res. 1977 Sep;37(9):3238–3242. [PubMed] [Google Scholar]
  46. Sachatello C. R. Colon cancer and cholestyramine. N Engl J Med. 1979 Nov 1;301(18):1007–1007. [PubMed] [Google Scholar]
  47. Silverberg E. Cancer statistics, 1981. CA Cancer J Clin. 1981 Jan-Feb;31(1):13–28. doi: 10.3322/canjclin.31.1.13. [DOI] [PubMed] [Google Scholar]
  48. Sykes J. A., Moddox I. S. Prostaglandin production by experimental tumours and effects of anti-inflammatory compounds. Nat New Biol. 1972 May 10;237(71):59–61. doi: 10.1038/newbio237059a0. [DOI] [PubMed] [Google Scholar]
  49. Thurnherr N., Deschner E. E., Stonehill E. H., Lipkin M. Induction of adenocarcinomas of the colon in mice by weekly injections of 1,2-dimethylhydrazine. Cancer Res. 1973 May;33(5):940–945. [PubMed] [Google Scholar]
  50. Ulland B. M., Weisburger J. H., Yamamoto R. S., Weisburger E. K. Antioxidants and carcinogenesis: butylated hydroxytoluene, but not diphenyl-p-phenylenediamine, inhibits cancer induction by N-2-fluorenylacetamide and by N-hydroxy-N-2-fluorenylacetamide in rats. Food Cosmet Toxicol. 1973 Apr;11(2):199–207. doi: 10.1016/s0015-6264(73)80486-9. [DOI] [PubMed] [Google Scholar]
  51. Vahouny G. V., Cassidy M. M., Lightfoot F., Grau L., Kritchevsky D. Ultrastructural modifications of intestinal and colonic mucosa induced by free or bound bile acids. Cancer Res. 1981 Sep;41(9 Pt 2):3764–3765. [PubMed] [Google Scholar]
  52. Vitale J. J., Broitman S. A. Lipids and immune function. Cancer Res. 1981 Sep;41(9 Pt 2):3706–3710. [PubMed] [Google Scholar]
  53. Webster H. D., Bollert J. A. Toxicologic, reproductive and teratologic studies of colestipol hydrochloride, a new bile acid sequestrant. Toxicol Appl Pharmacol. 1974 Apr;28(1):57–65. doi: 10.1016/0041-008x(74)90131-8. [DOI] [PubMed] [Google Scholar]
  54. Weisburger E. K., Evarts R. P. Inhibitory effect of butylated hydroxytoluene (BHT) on intestinal carcinogenesis in rats by azoxymethane. Food Cosmet Toxicol. 1977 Apr;15(2):139–141. doi: 10.1016/s0015-6264(77)80320-9. [DOI] [PubMed] [Google Scholar]
  55. Williamson R. C., Bauer F. L., Oscarson J. E., Ross J. S., Malt R. A. Promotion of azoxymethane-induced colonic neoplasia by resection of the proximal small bowel. Cancer Res. 1978 Oct;38(10):3212–3217. [PubMed] [Google Scholar]
  56. Williamson R. C., Bauer F. L., Terpstra O. T., Ross J. S., Malt R. A. Contrasting effects of subtotal enteric bypass, enterectomy, and colectomy on azoxymethane-induced intestinal carcinogenesis. Cancer Res. 1980 Mar;40(3):538–543. [PubMed] [Google Scholar]
  57. Wise A., Gilburt D. J. The variability of dietary fibre in laboratory animal diets and its relevance to the control of experimental conditions. Food Cosmet Toxicol. 1980 Dec;18(6):643–648. doi: 10.1016/s0015-6264(80)80013-7. [DOI] [PubMed] [Google Scholar]
  58. Wittig G., Wildner G. P., Ziebarth D. Der Einfluss der Ingesta auf die Kanzerisierung des Rattendarms durch Dimethylhydrazin. Arch Geschwulstforsch. 1971;37(2):105–115. [PubMed] [Google Scholar]
  59. Wynder E. L. Dietary habits and cancer epidemiology. Cancer. 1979 May;43(5 Suppl):1955–1961. doi: 10.1002/1097-0142(197905)43:5+<1955::aid-cncr2820430702>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  60. Yamamoto R. S. Effect of vitamin B12-deficiency in colon carcinogenesis. Proc Soc Exp Biol Med. 1980 Mar;163(3):350–353. doi: 10.3181/00379727-163-40776. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES